Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/8/25 17:21 | 9/6/24 | SERA | Health | Health | Medical Laboratories | Mirza Mansoor Raza | UT | D | 9 | S | -5 | 6.17 | 0 | -1 | 44 | D | ||||||||||||||||
3/10/25 17:26 | 8/7/24 | SERA | Health | Health | Medical Laboratories | Harrison Robert Gardner | UT | O | CIO | 11 | S.dm | -384 | 6.68 | 0 | -58 | 148 | D | |||||||||||||||
3/10/25 17:26 | 9/10/24 | SERA | Health | Health | Medical Laboratories | Lindgardt Zhenya | UT | DO | CEO | 10 | S.d | -1,673 | 7.43 | 0 | -225 | 947 | D | |||||||||||||||
3/10/25 17:25 | 9/10/24 | SERA | Health | Health | Medical Laboratories | Aerts Austin | UT | O | CFO | 13 | S.d | -518 | 7.53 | 0 | -69 | 331 | D | |||||||||||||||
3/7/25 19:29 | 8/7/24 | SERA | Health | Health | Medical Laboratories | Kearney Paul | UT | O | Chief Da | 9 | S.d | -367 | 7.47 | 0 | -49 | 204 | D | |||||||||||||||
3/7/25 19:29 | 8/7/24 | SERA | Health | Health | Medical Laboratories | Jackson Benjamin | UT | O | GC | 9 | S.dm | -471 | 6.73 | 0 | -70 | 158 | D | |||||||||||||||
3/7/25 19:28 | 8/7/24 | SERA | Health | Health | Medical Laboratories | Boniface John J. | UT | O | Chief Sc | 11 | S.dm | -1,373 | 8.82 | 0 | -156 | 194 | D | |||||||||||||||
1/14/25 21:56 | 1/10/25 | SERA | Health | Health | Medical Laboratories | Phillips Joshua | UT | D | 1 | S.m | -230 | 6.74 | 0 | -34 | -100 | 0 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |